Sustained release oral fampridine in the treatment of multiple sclerosis

By Kachuck Norman J  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 2025-2035

Informa Healthcare

Access to resources Recommend Favorite

Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis

By Fernandez Oscar   Berger Thomas   Hartung Hans-Peter   Putzki Norman  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 649-665

Informa Healthcare

Access to resources Recommend Favorite

Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU

By Lyseng-Williamson Katherine A.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

By Fineman Mark  

Clinical Pharmacokinetics, Vol. 50, Iss. 1, 2011-01 ,pp. : 65-74

Adis International

Access to resources Recommend Favorite

Single- and Multiple-Dose Pharmacokinetics and Tolerability of Gepirone Extended-Release

By Timmer C.J.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 819-826

Adis International

Access to resources Recommend Favorite